These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9140922)
1. Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease. Bongaerts GP; Lyerly DM Microb Pathog; 1997 Apr; 22(4):253-6. PubMed ID: 9140922 [No Abstract] [Full Text] [Related]
2. Role of toxins A and B in the pathogenesis of Clostridium difficile disease. Bongaerts GP; Lyerly DM Microb Pathog; 1994 Jul; 17(1):1-12. PubMed ID: 7861949 [No Abstract] [Full Text] [Related]
3. Clostridium difficile--more difficult than ever. Kelly CP; LaMont JT N Engl J Med; 2008 Oct; 359(18):1932-40. PubMed ID: 18971494 [No Abstract] [Full Text] [Related]
4. Analysis of the pathogenicity locus in Clostridium difficile strains. Cohen SH; Tang YJ; Silva J J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352 [TBL] [Abstract][Full Text] [Related]
6. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255 [TBL] [Abstract][Full Text] [Related]
7. Pseudomembranous colitis in children and adults. Bolton RP; Thomas DF Br J Hosp Med; 1986 Jan; 35(1):37-42. PubMed ID: 3955286 [TBL] [Abstract][Full Text] [Related]
8. Basic and clinical aspects of Clostridium difficile colitis. Morishita T; Nakayama T; Kamiya T; Mori S; Isobe K; Furuta Y Rev Gastroenterol Peru; 2004; 24(3):263-9. PubMed ID: 15483687 [TBL] [Abstract][Full Text] [Related]
9. Severe diarrhea and shock. Vora S; Glikman D; Kahanna M; Daum RS Pediatr Infect Dis J; 2006 Mar; 25(3):279, 284-5. PubMed ID: 16511400 [No Abstract] [Full Text] [Related]
10. Clostridium difficile-associated disease. Heins JR S D Med; 2006 Dec; 59(12):515-7. PubMed ID: 17212182 [No Abstract] [Full Text] [Related]
11. New trends in Clostridium difficile virulence and pathogenesis. Denève C; Janoir C; Poilane I; Fantinato C; Collignon A Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565 [TBL] [Abstract][Full Text] [Related]
12. [Physiopathology of Clostridium difficile-related intestinal disease. Role of the colonic ecosystem]. Marteau P; Sobhani I; Berretta O; Rambaud JC Gastroenterol Clin Biol; 1991; 15(4):322-9. PubMed ID: 2060744 [No Abstract] [Full Text] [Related]
13. [Pseudomembraneous colitis caused by a toxin B-positive and a toxin A-negative strain of Clostridium difficile]. Jakobsen L; Tvede M Ugeskr Laeger; 2006 Apr; 168(17):1634-5. PubMed ID: 16674873 [TBL] [Abstract][Full Text] [Related]
14. Introduction to the special issue on Clostridium difficile. Johnson S; Gerding DN Anaerobe; 2009 Dec; 15(6):225-6. PubMed ID: 19944988 [No Abstract] [Full Text] [Related]
15. [Clostridium difficile ribotype 027, toxinotype III in The Netherlands]. Kuijper EJ; Debast SB; Van Kregten E; Vaessen N; Notermans DW; van den Broek PJ Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2087-9. PubMed ID: 16201596 [TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile and fluoroquinolones: is there a link? Weiss K Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566 [TBL] [Abstract][Full Text] [Related]